Abstract
MicroRNA (miRNA) has been reported to exert important functions in papillary thyroid carcinomas (PTC). However, the role of miRNA in aggressive PTC (APTC) remains unclear. Here, we investigated the diagnostic potentials and mechanisms of miR-221/222 in APTC. Results showed that miR-221/222 were markedly up-regulated in PTC, compared with the adjacent normal tissue (ANT). A high expression of miR-221/222 were associated with a primary tumor, regional lymph node, and distant metastasis (TNM) stage, multicentricity, lymph node metastasis, and extra-thyroidal extension. Receiver operating characteristic (ROC) curve analysis indicated that miR-221/222 could be used as APTC diagnostic markers. Moreover, miR-221/222 tremendously promoted migration and invasion and inhibited apoptosis and autophagy in PTC cells. A luciferase assay showed that miR-221/222 inhibited the fluorescent activity of autophagy-related protein 10 (ATG10). Furthermore, miR-221/222 decreased ATG10 mRNA and protein levels. Silencing of ATG10 significantly abrogated the effect of miR-221/222 on apoptosis and autophagy. We suggested that miR-221/222 can promote migration and invasion, and inhibit autophagy and apoptosis by targeting ATG10 in APTC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Cao QH, Liu F, Yang ZL et al (2016) Prognostic value of autophagy related proteins ULK1, Beclin 1, ATG3, ATG5, ATG7, ATG9, ATG10, ATG12, LC3B and p62/SQSTM1 in gastric cancer. Am J Transl Res 8:3831–3847
Costa AM, Herrero A, Fresno MF et al (2008) BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol 68(4):618–634. https://doi.org/10.1111/j.1365-2265.2007.03077.x
Dai L, Wang Y, Chen L, Zheng J, Li J, Wu X (2017) MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer. World J Surg Oncol 15:11. https://doi.org/10.1186/s12957-016-1086-z
Danysh BP, Rieger EY, Sinha DK, Evers CV, Cote GJ, Cabanillas ME, Hofmann M-C (2016) Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model. Oncotarget 7:30907–30923. https://doi.org/10.18632/oncotarget.9023
Deng L, Lei Q, Wang Y et al (2017) Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis. Oncotarget 8:108712–108725. https://doi.org/10.18632/oncotarget.21561
Di Martino MT, Rossi M, Caracciolo D, Gulla A, Tagliaferri P, Tassone P (2016) Mir-221/222 are promising targets for innovative anticancer therapy. Expert Opin Ther Targets 20:1099–1108. https://doi.org/10.1517/14728222.2016.1164693
Diao Y, Fu H, Wang Q (2017) MiR-221 exacerbate cell proliferation and invasion by targeting TIMP3 in papillary thyroid carcinoma. Am J Ther 24:e317–e328. https://doi.org/10.1097/MJT.0000000000000420
Eszlinger M, Lau L, Ghaznavi S, Symonds C, Chandarana SP, Khalil M, Paschke R (2017) Molecular profiling of thyroid nodule fine-needle aspiration cytology. Nat Rev Endocrinol 13:415–424. https://doi.org/10.1038/nrendo.2017.24
Galardi S, Mercatelli N, Farace MG, Ciafre SA (2011) NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res 39:3892–3902. https://doi.org/10.1093/nar/gkr006
Gomes LC, Dikic I (2014) Autophagy in antimicrobial immunity. Mol Cell 54(2):224–233. https://doi.org/10.1016/j.molcel.2014.03.009
Gugnoni M, Sancisi V, Manzotti G, Gandolfi G, Ciarrocchi A (2016) Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer. Cell Death Dis 7:e2520. https://doi.org/10.1038/cddis.2016.415
He H, Jazdzewski K, Li W et al (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102:19075–19080. https://doi.org/10.1073/pnas.0509603102
Jeon HM, Lim BJ, Chang HS, Hong S (2012) The definition of minimal extrathyroid extension in thyroid pathology by analyzing sizable intra- and extrathyroid blood vessels. Korean J Pathol 46:548–553. https://doi.org/10.4132/KoreanJPathol.2012.46.6.548
Jeong G, Lim YH, Kim NJ, Wee G, Kim YK (2017) Knockout of miR-221 and miR-222 reveals common and specific targets for paralogous miRNAs. RNA Biol 14:197–205. https://doi.org/10.1080/15476286.2016.1269994
Jo YK, Kim SC, Park IJ et al (2012) Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis. PLoS ONE 7:e52705. https://doi.org/10.1371/journal.pone.0052705
Karakaş HE, Gözüaçik D (2014) Autophagy and cancer. Turkish J Biol 38(6):720–739. https://doi.org/10.3906/biy-1408-16
Kim KM, Park JB, Bae KS, Kang SJ (2012) Analysis of prognostic factors in patients with multiple recurrences of papillary thyroid carcinoma. Surg Oncol 21:185–190. https://doi.org/10.1016/j.suronc.2011.07.004
Kitahara CM, Sosa JA (2016) The changing incidence of thyroid cancer. Nat Rev Endocrinol 12:646–653. https://doi.org/10.1038/nrendo.2016.110
Lee JC, Zhao JT, Clifton-Bligh RJ et al (2013) MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer 119:4358–4365. https://doi.org/10.1002/cncr.28254
Lemcke H, David R (2018) Potential mechanisms of miRNA mobility. Traffic 19:910–917. https://doi.org/10.1111/tra.12606
Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132:27–42. https://doi.org/10.1016/j.cell.2007.12.018
Liao D, Li T, Ye C et al (2018) miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells. Exp Ther Med 15:1712–1717. https://doi.org/10.3892/etm.2017.5522
Mathew R, Karantza-Wadsworth V, White E (2007) Role of autophagy in cancer. Nat Rev Cancer 7:961–967. https://doi.org/10.1038/nrc2254
Mizushima N (2007) Autophagy: process and function. Genes Dev 21:2861–2873. https://doi.org/10.1101/gad.1599207
Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y (2009) Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol 10:458–467. https://doi.org/10.1038/nrm2708
Ning T, Zhang H, Wang X et al (2017) miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer. Tumour Biol 39:1010428317701636. https://doi.org/10.1177/1010428317701636
Shah MY, Calin GA (2011) MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med 3:56. https://doi.org/10.1186/gm272
Sherman SI (2003) Thyroid carcinoma. Lancet 361:501–511. https://doi.org/10.1016/S0140-6736(03)12488-9
Song J, Ouyang Y, Che J et al (2017) Potential value of miR-221/222 as diagnostic, prognostic, and therapeutic biomarkers for diseases. Front Immunol 8:56. https://doi.org/10.3389/fimmu.2017.00056
Sredni ST, Bonaldo Mde F, Costa FF et al (2010) Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. Childs Nerv Syst 26:279–283. https://doi.org/10.1007/s00381-009-1028-y
Wang TS, Sosa JA (2018) Thyroid surgery for differentiated thyroid cancer—recent advances and future directions. Nat Rev Endocrinol 14:670–683. https://doi.org/10.1038/s41574-018-0080-7
Wang S, Xia P, Huang G et al (2016a) FoxO1-mediated autophagy is required for NK cell development and innate immunity. Nat Commun 7:11023. https://doi.org/10.1038/ncomms11023
Wang SF, Wu MY, Cai CZ, Li M, Lu JH (2016b) Autophagy modulators from traditional Chinese medicine: Mechanisms and therapeutic potentials for cancer and neurodegenerative diseases. J Ethnopharmacol 194:861–876. https://doi.org/10.1016/j.jep.2016.10.069
Xie Z, Klionsky DJ (2007) Autophagosome formation: core machinery and adaptations. Nat Cell Biol 9:1102–1109. https://doi.org/10.1038/ncb1007-1102
Xie K, Liang C, Li Q et al (2016) Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival. Int J Cancer 139:1564–1573. https://doi.org/10.1002/ijc.30205
Yang Y, Zhao X, Li HX (2016) MiR-221 and miR-222 simultaneously target ARID1A and enhance proliferation and invasion of cervical cancer cells. Eur Rev Med Pharmacol Sci 20:1509–1515
Yang Y, Sun Y, Wang H et al (2018) MicroRNA-221 induces autophagy through suppressing HDAC6 expression and promoting apoptosis in pancreatic cancer. Oncol Lett 16:7295–7301. https://doi.org/10.3892/ol.2018.9513
Yu C, Gorantla SP, Muller-Rudorf A et al (2019) Phosphorylation of Beclin-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia. Haematologica. https://doi.org/10.3324/haematol.2018.212027
Zhang R, Pang B, Xin T et al (2016) Plasma miR-221/222 family as novel descriptive and prognostic biomarkers for glioma. Mol Neurobiol 53:1452–1460. https://doi.org/10.1007/s12035-014-9079-9
Zhao Q, Hu ZY, Zhang JP et al (2017) Dual roles of two isoforms of autophagy-related gene ATG10 in HCV-subgenomic replicon mediated autophagy flux and innate immunity. Sci Rep 7(1):11250. https://doi.org/10.1038/s41598-017-11105-3
Zheng BAKT, Holford TR, Han X et al (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20:525–531. https://doi.org/10.1007/s10552-008-9260-4
Funding
This work was sponsored by the third batch of ten hundred thousand project of health and family planning system in Jing’An district, Shanghai (JWRC2014Q13).
Author information
Authors and Affiliations
Contributions
Conceptualization and funding acquisition: XY. Data curation: HS and ZL. Formal analysis: HY and LW. Investigation: HS, ZL, BM and HL. Methodology:BY, SH and ZL. Writing—original draft: HS and ZL. Writing—review and editing: HS, WL, JT and HY. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethics approval and consent to participate
This study was approved by the Ethics Committee (number: 2016-39) of Jing’An District Central Hospital (Shanghai, China). Written informed consent forms were obtained from all the subjects and their patients in this study.
Patient consent for publication
All patients provided informed consent and agreed to publish.
Rights and permissions
About this article
Cite this article
Shen, H., Lin, Z., Shi, H. et al. MiR-221/222 promote migration and invasion, and inhibit autophagy and apoptosis by modulating ATG10 in aggressive papillary thyroid carcinoma. 3 Biotech 10, 339 (2020). https://doi.org/10.1007/s13205-020-02326-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-020-02326-x